---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-204308"
form_type: "8-K"
ticker: "OVID"
cik: "0001636651"
company_name: "Ovid Therapeutics Inc."
filed_at: "2025-09-16T23:59:59+00:00"
generated_at: "2026-05-17T06:30:07.858324+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Ovid Therapeutics regains compliance with Nasdaq minimum bid price rule

## Summary
- Received formal notice from Nasdaq on Sept 11, 2025, confirming compliance with Listing Rule 5550(a)(2).
- Minimum bid price had been below $1.00; company now meets the requirement.
- Nasdaq has closed the matter; no further action needed regarding listing status.
- Stock trading symbol OVID remains on The Nasdaq Stock Market LLC.

## SEC filing metadata
- accession: 0001193125-25-204308
- form_type: 8-K
- ticker: OVID
- cik: 0001636651
- company_name: Ovid Therapeutics Inc.
- filed_at: 2025-09-16T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636651/000119312525204308/0001193125-25-204308-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636651/000119312525204308/d80889d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-204308
- JSON: https://secwatch.observer/filing/0001193125-25-204308.json
- Plain text: https://secwatch.observer/filing/0001193125-25-204308.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.